CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo
dc.contributor.author | Talbott, Jason F. | |
dc.contributor.author | Cao, Qilin | |
dc.contributor.author | Bertram, James | |
dc.contributor.author | Nkansah, Michael | |
dc.contributor.author | Benton, Richard L. | |
dc.contributor.author | Lavik, Erin | |
dc.contributor.author | Whittemore, Scott R. | |
dc.date.accessioned | 2021-03-19T18:16:41Z | |
dc.date.available | 2021-03-19T18:16:41Z | |
dc.date.issued | 2006-12-20 | |
dc.description.abstract | Delivery of factors capable of promoting oligodendrocyte precursor cell (OPC) survival and differentiation in vivo is an important therapeutic strategy for a variety of pathologies in which demyelination is a component, including multiple sclerosis and spinal cord injury. Ciliary neurotrophic factor (CNTF) is a neuropoietic cytokine that promotes both survival and maturation of a variety of neuronal and glial cell populations, including oligodendrocytes. Present results suggest that, although CNTF has a potent survival and differentiation promoting effect in vitro on OPCs isolated from the adult spinal cord, CNTF administration in vivo is not sufficient to promote oligodendrocyte remyelination in the glial-depleted environment of unilateral ethidium bromide (EB) lesions. | en_US |
dc.description.sponsorship | This research was supported by NS38665, RR15576, the Kentucky Spinal Cord and Head Injury Research Trust, Norton Healthcare, and the Commonwealth of Kentucky Research Challenge for Excellence Trust Fund. | en_US |
dc.description.uri | https://www.sciencedirect.com/science/article/abs/pii/S0014488606006376 | en_US |
dc.format.extent | 9 pages | en_US |
dc.genre | journal articles postprints | en_US |
dc.identifier | doi:10.13016/m2hlsy-4zft | |
dc.identifier.citation | Jason F. Talbott, Qilin Cao et al., CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo, Exp Neurol. 2007 March ; 204(1): 485–489, DOI: https://doi.org/10.1016/j.expneurol.2006.12.013 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.expneurol.2006.12.013 | |
dc.identifier.uri | http://hdl.handle.net/11603/21201 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
dc.relation.ispartof | UMBC Chemical, Biochemical & Environmental Engineering Department Collection | |
dc.rights | This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo | en_US |
dc.type | Text | en_US |